The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAGR.L Regulatory News (BAGR)

  • There is currently no data for BAGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Directorate Change

31 Dec 2018 07:00

RNS Number : 7755L
Bagir Group Ltd
31 December 2018
 

31 December 2018

 

Bagir Group Limited

("Bagir" or the "Company")

 

Trading Update and Directorate Change

  

Bagir (AIM: BAGR), a designer, creator and provider of innovative tailoring, announces that it is taking more time than first envisaged for Shandong Ruyi to receive Chinese Government approval for its proposed $16.5 million investment into the Company in return for 359,560,310 New Ordinary Shares representing 53.7 per cent of the Company's Enlarged Share Capital. As a consequence, the Company has agreed a new unconditional completion date for the transaction of 30 May 2019 by which time Shandong Ruyi will pay the remaining cash payment of $13.2 million. All other conditions relating to the transaction have been completed by Bagir.

Current Trading

The Board of Bagir is pleased to confirm that the Company is trading in line with management expectations for the 12 months to 31 December 2018. As anticipated, trading in the second half has been stronger compared to the first 6 months, with the Company recording a profitable third and fourth quarter.

Directorate Change

Udi Cohen, Chief Financial Officer, has decided to leave the Company from March 10, 2019, to pursue his other business interests. Dotan Levy currently Group Financial Controller will take on the role of acting Chief Financial Officer. Dotan will not become a director of the Company at this time.

Chief Executive Officer, Eran Itzhak, said: "While both ourselves and Shandong Ruyi would have preferred to have completed the transaction earlier, both companies are committed to making this partnership work. Shandong Ruyi remain confident the transaction will be completed and the new completion date has been set to provide ample time for all parties.

On behalf of the Board I would like thank Udi who has worked for Bagir for 7 years and has been a highly valued colleague to all of us and we wish him well in the future."

For further information please contact:

Bagir Group Limited

Eran Itzhak, Chief Executive Officer

Udi Cohen, Chief Financial Officer

Tessa Laws, Non-Executive Chairman

 

via Novella on:

+44 (0) 20 3151 7008

N+1 Singer (Nominated Adviser & Broker)

Mark Taylor

James Moat

 

+44 (0)20 7496 3000

Novella Communications (Financial PR)

Tim Robertson

Toby Andrews

+44 (0)20 3151 7008

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFKKDPKBDBNBN
Date   Source Headline
31st Dec 201812:40 pmRNSSecond Price Monitoring Extn
31st Dec 201812:35 pmRNSPrice Monitoring Extension
31st Dec 20187:00 amRNSTrading Update and Directorate Change
8th Nov 20184:41 pmRNSHolding(s) in Company
31st Oct 20183:29 pmRNSHolding(s) in Company
9th Oct 201811:45 amRNSResult of EGM
21st Sep 20187:00 amRNSHalf-year Report
4th Sep 20185:30 pmRNSResult of AGM
3rd Sep 20187:00 amRNSStrategic Partnership and Notice of EGM
31st Jul 20188:20 amRNSHolding(s) in Company
25th Jul 20185:15 pmRNSNotice of AGM
18th Jul 20184:35 pmRNSPrice Monitoring Extension
18th Jul 20183:35 pmRNSHolding(s) in Company
18th Jul 201811:00 amRNSPrice Monitoring Extension
18th Jul 20187:00 amRNSUpdate on Strategic Partnership
29th Jun 20183:34 pmRNSPosting of Annual Report
14th Jun 20182:05 pmRNSSecond Price Monitoring Extn
14th Jun 20182:00 pmRNSPrice Monitoring Extension
13th Jun 20184:40 pmRNSSecond Price Monitoring Extn
13th Jun 20184:35 pmRNSPrice Monitoring Extension
13th Jun 20182:06 pmRNSSecond Price Monitoring Extn
13th Jun 20182:00 pmRNSPrice Monitoring Extension
23rd May 20187:00 amRNSUpdate relating to strategic partnership
20th Apr 20184:10 pmRNSHolding(s) in Company
4th Apr 20189:26 amRNSHolding(s) in Company
7th Mar 20187:00 amRNSFinal Results
9th Jan 201811:00 amRNSUpdate relating to strategic partnership
4th Jan 20188:00 amRNSUpdate relating to strategic partnership
27th Dec 201711:01 amRNSDirector Dealing
19th Dec 20174:00 pmRNSHolding(s) in Company
18th Dec 20179:36 amRNSHolding(s) in Company
7th Dec 201711:05 amRNSSecond Price Monitoring Extn
7th Dec 201711:00 amRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSBagir signs MoU with tailoring app Sizer
4th Dec 20174:40 pmRNSSecond Price Monitoring Extn
4th Dec 20174:35 pmRNSPrice Monitoring Extension
30th Nov 20173:59 pmRNSUpdate relating to strategic partnership
27th Nov 201712:52 pmRNSHolding(s) in Company
23rd Nov 20177:30 amRNSRestoration - Bagir Group Limited
23rd Nov 20177:00 amRNSStrategic investor and restoration of trading
20th Nov 20171:00 pmRNSStatement re. Suspension
20th Nov 201712:10 pmRNSSuspension - Bagir Group Limited
20th Nov 20177:00 amRNSTrading Update and Possible Strategic Investor
24th Oct 20174:40 pmRNSSecond Price Monitoring Extn
24th Oct 20174:35 pmRNSPrice Monitoring Extension
22nd Sep 20173:25 pmRNSHolding(s) in Company
13th Sep 20177:55 amRNSHalf-year Report
13th Sep 20177:00 amRNSHalf-year Report
11th Sep 20179:55 amRNSHolding(s) in Company
29th Aug 20178:52 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.